Determination of the density distribution of human platelets--methodological aspects and comparison with other tests for platelet activation.
Stimulation of human platelets to release results in decreased buoyant density. This decreased density provides a tool to detect circulating platelets which have participated in a thrombotic process. Platelet density gradient centrifugation using Stractan was standardized and the effects of anticoagulation, temperature, and osmolarity were investigated. In 7 out of 32 patients with thrombotic disease less dense platelets were found. Platelet activation in the patient group was also indicated by spontaneous aggregation (10/32), decreased circulating platelet aggregate ratios (5/24) and elevated plasma beta-thromboglobulin levels (2/ 11). Several of these tests were also abnormal in diabetes mellitus thrombocytosis, leukaemia and several systemic diseases with thrombotic complications. The platelet density test using Stractan is reproducible and independent of other tests for platelet activation and is therefore potentially a useful extension of platelet function testing in patients with thrombotic disease.
D000328:Adult; D000925:Anticoagulants / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D002546:Ischemic Attack, Transient / Q000097:blood / Q000175:diagnosis; D007938:Leukemia / Q000097:blood / Q000150:complications / Q000175:diagnosis; D009994:Osmolar Concentration; D010974:Platelet Aggregation; D010976:Platelet Count; D010979:Platelet Function Tests; D013696:Temperature; D013922:Thrombocytosis / Q000097:blood / Q000150:complications / Q000175:diagnosis
D000925:Anticoagulants